JULIE SAUNDERS
Broker in Bourne, MA

License number
Massachusetts 9033555
Issued Date
Jan 15, 2000
Expiration Date
Apr 8, 2010
Type
Salesperson
Address
Address
Bourne, MA 02559

Professional information

Julie Saunders Photo 1

Compositions For Topical Enzymatic Debridement

US Patent:
2005028, Dec 22, 2005
Filed:
Jun 8, 2005
Appl. No.:
11/147567
Inventors:
Mark Trumbore - Westford MA, US
Roman Rariy - Allston MA, US
Mark Hirsh - Wellesley MA, US
Jane Hirsh - Wellesley MA, US
Julie Saunders - Pocasset MA, US
International Classification:
A61K038/46, A61K033/38, A61K033/36, A61K035/78
US Classification:
424094650, 424618000, 424770000, 424195180, 424672000
Abstract:
Formulations are described for the treatment by enzymatic debridement of wounds and ulcers. The formulations have a clear, transparent composition that allows for easy visualization of the wound, and are non-staining for easy clean up. These formulations can also exhibit increased enzymatic debridement activity, improved post-treatment lubricity and coating occlusivity, and stability. The formulations, optionally containing non-animal source biologics, may be in the form of lotions, aerosols to provide a spray, or a foam. A non-reactive substrate may be used as a composition carrier. A non-aqueous lotion formulation having improved enzymatic activity is provided. The non-aqueous lotion viscosity is adjusted to achieve high enzymatic activity while maintaining the application benefits of high viscosity non-aqueous lotions. The lotion formulation may be delivered in a patch.


Julie Saunders Photo 2

Compositions For Topical Enzymatic Debridement

US Patent:
2008001, Jan 17, 2008
Filed:
Aug 22, 2007
Appl. No.:
11/843158
Inventors:
Mark Trumbore - Westford MA, US
Roman Rariy - Allston MA, US
Mark Hirsh - Wellesley MA, US
Jane Hirsh - Wellesley MA, US
Julie Saunders - Pocasset MA, US
International Classification:
A61K 31/74, A61K 33/38, A61K 35/00, A61K 38/43, A61P 17/00
US Classification:
424078080, 424195180, 424618000, 424094100
Abstract:
Formulations are described for the treatment by enzymatic debridement of wounds and ulcers. The formulations have a clear, transparent composition that allows for easy visualization of the wound, and are non-staining for easy clean up. These formulations can also exhibit increased enzymatic debridement activity, improved post-treatment lubricity and coating occlusivity, and stability. The formulations, optionally containing non-animal source biologics, may be in the form of lotions, aerosols to provide a spray, or a foam. A non-reactive substrate may be used as a composition carrier. A non-aqueous lotion formulation having improved enzymatic activity is provided. The non-aqueous lotion viscosity is adjusted to achieve high enzymatic activity while maintaining the application benefits of high viscosity non-aqueous lotions. The lotion formulation may be delivered in a patch.